Skip to Main Content

Paper Details

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
Allergy
3
2023
Author NameAffiliation
Daniel J JacksonUniversity of Wisconsin School of Medicine and Public Health
  • 1 - 1

Datasets

Release 1.2